Skip to main content

Table 1 Overview of research themes and questions regarding early assessment

From: A qualitative exploration of early assessment of innovative medical technologies

Theme

Questions

1) Context

What is the time horizon in the developmental process?

How many technologies/ideas do you evaluate in one year – rough estimate of the size of your portfolio of projects?

2) Foundation/basis for decision making

Is there an approach/template for early assessments? Do you use a fixed/systematic procedure?

What are the dimensions/inputs in the early assessment - Which components are used?

• Do you use qualitative data/information?

• Do you use quantitative data/information?

• Is there an economic calculation (even simple) in the pilot phase?

• Are expected clinical effects included early – for example mortality, amputations, admissions?

Do you perform risk/uncertainty assessments?

3) Process and structure of early assessment

Which phases are used in the developmental process?

Are there stop/go decisions in the process of development – what are they based on?

Do you update your assessments regularly – how often?

Who decides whether to continue an innovation - who makes the go/no-go decision?

How do you decide which effects to include?

Success ratea: Which proportion of projects/ideas survives the “pilot phase” and achieves routine use or commercialisation?

4) Perceptions

Relevance and satisfaction with the used method?

What are the pros? And what are the cons (wish list)?

  1. aDefinition of success rate: The proportion of an organisation’s R&D product portfolio that “survives” the early phases in the developmental process and becomes a “success”. While success in the public sector is defined by the product achieving routine use, in the private sector the product must be commercialised or launched on the market to be termed a success